Auxochromofours Solutions Private Limited logo

Auxochromofours Solutions Private Limited

Life science and pharmaceutical product development, offering diagnostic tests and innovative formulations.
2018 | Bangaluru, Karnataka (India) | Active

Last Updated:

December 19, 2024
HomeCompanyAuxochromofours Solutions Private Limited

Who are the key members and board of directors at Auxochromofours Solutions?

Board Members(2)

NameDesignationAppointment DateStatus
Shreyas Burji In Director 10-Dec-2018Current
Hemmige Basavaraj In Director 10-Dec-2018Current

Financial Performance of Auxochromofours Solutions.

Auxochromofours Solutions Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 32.63% increase. The company also saw a substantial improvement in profitability, with a 2750.4% increase in profit. The company's net worth Soared by an impressive increase of 23.07%.

Revenue Growth Graph
Profit Loss Graph
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metric
(FY 2023)YOY Growth
(FY 2022)(FY 2021)(FY 2020)(FY 2019)
Total Revenue
32.63%
Revenue from Operations
32.32%
Total Assets
972.94%
Profit or Loss
2750.40%
Net Worth
23.07%
EBITDA
529.61%

Charges (Loans)

Charges

There are no open charges registered against the company as per our records.

How Many Employees Work at Auxochromofours Solutions?

Unlock and access historical data on people associated with Auxochromofours Solutions, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.

Employee Graph

Deals i

Rating

Alerts

Latest Updates, News, and FAQs on Auxochromofours Solutions

Recent activity within the organization

  • Annual General Meeting

    Auxochromofours Solutions Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records.

    30 Sep 2024

  • Balance Sheet

    Auxochromofours Solutions Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Bangalore.

    31 Mar 2024

  • Director Appointment

    Shreyas Mrityunjaya Burji was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 6 years 15 days .

    10 Dec 2018

  • Director Appointment

    Hemmige Channabasavanna Basavaraj was appointed as a Director was appointed as a Director on 10 Dec 2018 & has been associated with this company since 6 years 15 days .

    10 Dec 2018

  • Company Incorporation

    Auxochromofours Solutions Private Limited was registered on 10 Dec 2018 with Roc Bangalore & aged 6 years 15 days as per MCA records.

    10 Dec 2018

Frequently asked questions

  • Auxochromofours Solutions Private Limited was incorporated on 10 Dec 2018.

  • The authorized share capital of Auxochromofours Solutions Private Limited is ₹ 5.00 M and paid-up capital is ₹ 4.00 M.

  • Currently 2 directors are associated with Auxochromofours Solutions Private Limited.

    • Shreyas Mrityunjaya Burji
    • Hemmige Channabasavanna Basavaraj
  • As per Ministry of Corporate Affairs (Mca), the registered address of Auxochromofours Solutions Private Limited is No.852 12Th Main Vinayaka Layout Nagarbhavi 2Nd Stage, India, Bangalore, Karnataka, 560072.

  • The corporate identification number (CIN) of Auxochromofours Solutions Private Limited is U36900KA2018PTC119294 and the company number is 119294 as per Ministry of Corporate Affairs (MCA).

  • The Official website of Auxochromofours Solutions Private Limited is https://www.auxochromofours.com

  • According to the financial reports for the fiscal year 2021, the revenue trend for Auxochromofours Solutions Private Limited has risen by 32.63%.

  • The financial reports for the fiscal year 2021 indicates that The net worth of Auxochromofours Solutions Private Limited has experienced an upsurge of 23.07%.

  • The most recent Balance Sheet for Auxochromofours Solutions Private Limited was filed with the ROC on 31 Mar 2024.

Similar Companies Based on Pharma Contract R&D